Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001592730 | SCV001823300 | likely benign | not provided | 2020-06-08 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276841 | SCV002566294 | uncertain significance | Ehlers-Danlos syndrome | 2021-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368621 | SCV002660570 | likely benign | Cardiovascular phenotype | 2020-07-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002501962 | SCV002812623 | likely benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003948638 | SCV004765809 | likely benign | TNXB-related disorder | 2019-11-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |